216 related articles for article (PubMed ID: 25281223)
1. MDMA: a social drug in a social context.
Kirkpatrick MG; de Wit H
Psychopharmacology (Berl); 2015 Mar; 232(6):1155-63. PubMed ID: 25281223
[TBL] [Abstract][Full Text] [Related]
2. MDMA alters emotional processing and facilitates positive social interaction.
Wardle MC; de Wit H
Psychopharmacology (Berl); 2014 Oct; 231(21):4219-29. PubMed ID: 24728603
[TBL] [Abstract][Full Text] [Related]
3. Effects of MDMA and Intranasal oxytocin on social and emotional processing.
Kirkpatrick MG; Lee R; Wardle MC; Jacob S; de Wit H
Neuropsychopharmacology; 2014 Jun; 39(7):1654-63. PubMed ID: 24448644
[TBL] [Abstract][Full Text] [Related]
4. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.
Dumont GJ; Sweep FC; van der Steen R; Hermsen R; Donders AR; Touw DJ; van Gerven JM; Buitelaar JK; Verkes RJ
Soc Neurosci; 2009; 4(4):359-66. PubMed ID: 19562632
[TBL] [Abstract][Full Text] [Related]
5. MDMA does not alter responses to the Trier Social Stress Test in humans.
Bershad AK; Miller MA; de Wit H
Psychopharmacology (Berl); 2017 Jul; 234(14):2159-2166. PubMed ID: 28432376
[TBL] [Abstract][Full Text] [Related]
6. Effects of MDMA on sociability and neural response to social threat and social reward.
Bedi G; Phan KL; Angstadt M; de Wit H
Psychopharmacology (Berl); 2009 Nov; 207(1):73-83. PubMed ID: 19680634
[TBL] [Abstract][Full Text] [Related]
7. MDMA enhances emotional empathy and prosocial behavior.
Hysek CM; Schmid Y; Simmler LD; Domes G; Heinrichs M; Eisenegger C; Preller KH; Quednow BB; Liechti ME
Soc Cogn Affect Neurosci; 2014 Nov; 9(11):1645-52. PubMed ID: 24097374
[TBL] [Abstract][Full Text] [Related]
8. 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.
Wardle MC; Kirkpatrick MG; de Wit H
Soc Cogn Affect Neurosci; 2014 Aug; 9(8):1076-81. PubMed ID: 24682132
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting.
Baggott MJ; Coyle JR; Siegrist JD; Garrison KJ; Galloway GP; Mendelson JE
J Psychopharmacol; 2016 Apr; 30(4):378-87. PubMed ID: 26880224
[TBL] [Abstract][Full Text] [Related]
10. Intimate insight: MDMA changes how people talk about significant others.
Baggott MJ; Kirkpatrick MG; Bedi G; de Wit H
J Psychopharmacol; 2015 Jun; 29(6):669-77. PubMed ID: 25922420
[TBL] [Abstract][Full Text] [Related]
11. Prosocial effects of MDMA: A measure of generosity.
Kirkpatrick M; Delton AW; Robertson TE; de Wit H
J Psychopharmacol; 2015 Jun; 29(6):661-8. PubMed ID: 25735993
[TBL] [Abstract][Full Text] [Related]
12. MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.
Hysek CM; Domes G; Liechti ME
Psychopharmacology (Berl); 2012 Jul; 222(2):293-302. PubMed ID: 22277989
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
Farré M; Abanades S; Roset PN; Peiró AM; Torrens M; O'Mathúna B; Segura M; de la Torre R
J Pharmacol Exp Ther; 2007 Dec; 323(3):954-62. PubMed ID: 17890444
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of MDMA and methylphenidate on social cognition.
Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME
J Psychopharmacol; 2014 Sep; 28(9):847-56. PubMed ID: 25052243
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment.
Borissova A; Ferguson B; Wall MB; Morgan CJ; Carhart-Harris RL; Bolstridge M; Bloomfield MA; Williams TM; Feilding A; Murphy K; Tyacke RJ; Erritzoe D; Stewart L; Wolff K; Nutt D; Curran HV; Lawn W
J Psychopharmacol; 2021 May; 35(5):547-555. PubMed ID: 32538252
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin receptor gene variation predicts subjective responses to MDMA.
Bershad AK; Weafer JJ; Kirkpatrick MG; Wardle MC; Miller MA; de Wit H
Soc Neurosci; 2016 Dec; 11(6):592-9. PubMed ID: 26787430
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the subjective effects of MDMA.
Liechti ME; Gamma A; Vollenweider FX
Psychopharmacology (Berl); 2001 Mar; 154(2):161-8. PubMed ID: 11314678
[TBL] [Abstract][Full Text] [Related]
18. Human Pharmacology of Mephedrone in Comparison with MDMA.
Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
[TBL] [Abstract][Full Text] [Related]
19. Greater empathy in MDMA users.
Carlyle M; Stevens T; Fawaz L; Marsh B; Kosmider S; Morgan CJ
J Psychopharmacol; 2019 Mar; 33(3):295-304. PubMed ID: 30717615
[TBL] [Abstract][Full Text] [Related]
20. The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Tancer M; Johanson CE
Psychopharmacology (Berl); 2007 Jan; 189(4):565-73. PubMed ID: 17047932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
